BRIEF published on 06/11/2024 at 16:35, 1 year 5 months ago Plotly Wins 2024 Databricks Customer Impact Partner of the Year Award AI Plotly Databricks Customer Impact Data Applications
PRESS RELEASE published on 06/11/2024 at 16:30, 1 year 5 months ago Plotly Wins 2024 Databricks Customer Impact Partner of the Year Award Plotly is awarded the 2024 Customer Impact Partner of the Year by Databricks, showcasing business value. Thousands of customers benefit from the partnership's data app platform Data Insights Plotly Databricks Customer Impact Partner Interactive Visualizations
PRESS RELEASE published on 12/04/2023 at 18:25, 2 years ago Plotly Shares Details of New AI Features in the Upcoming Dash Enterprise 5.2 Release Plotly unveils AI capabilities in the upcoming Dash Enterprise 5.2 release, including Smart Insights and an AI-powered documentation chatbot to enhance data application development AI Capabilities Plotly Dash Enterprise 5.2 Smart Insights Documentation Chatbot
PRESS RELEASE published on 11/29/2023 at 17:00, 2 years ago Announcing Plotly App Studio, a Tool to Drastically Simplify Data App Development
Published on 12/05/2025 at 02:35, 1 hour 54 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 29 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 24 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 29 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 58 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 38 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 3 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 14 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 18 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 29 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 44 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 45 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 28 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025
